Search This Site

Search this Site

Some on Testosterone

November 29, 2016

If you have lingering doubts regarding the safety of testosterone therapy in light of recent media hype, lawyer’s ads and even the FDA statement released on March 3rd, read what the medical experts at Harvard and The Mayo Clinic have to say.

A 2015 review in the Mayo Clinic Proceedings, titled Testosterone Therapy and Cardiovascular Risk: Advances and Controversies, concluded: “In summary, there is no convincing evidence of increased CV (cardiovascular) risks with T (testosterone) therapy. On the contrary, there appears to be a strong beneficial relationship between normal T and CV health that has not yet been widely appreciated.”

You also might want to read the article in Science Daily featuring Harvard urologist, Dr. Abraham Morgentaler: Analysis rejects linkage between testosterone therapy, cardiovascular risk.

It is difficult to understand what prompted the latest FDA statement when trusted medical experts at the Mayo Clinic and Harvard indicate otherwise. As your physician I try to provide you with the information needed to draw your own conclusions.

Testosterone replacement (TRT) in men who are deficient has multiple health benefits and can be truly life changing. However, TRT is viewed with great skepticism by many in the medical community. Recently, two poorly done studies questioned the cardiovascular safety of testosterone, only fueling the controversy. These 2 studies have been largely discredited.

Literally, for decades, there has probably been no greater medical myth than the notion that testosterone causes prostate cancer. While not a single study supports this idea, generations of physicians have been trained that testosterone is fuel for prostate cancer, like “pouring gasoline on a fire,” as if this were written in stone. There have been numerous studies that failed to reveal any correlation between testosterone levels and the risk of prostate cancer. Nonetheless, many in the medical community insist that supplementing with testosterone will increase ones risk, citing the lack of long-term safety studies.

A new study in The Journal of Urology dispels this long held medical myth. 1023 men on testosterone replacement were followed for up to 17 years. The researchers found that there was no increase in the risk of prostate cancer compared to the general population. In fact, the risk of developing prostate cancer in the testosterone treated men was less than half that of the general population.

This is no surprise and is consistent with my experience.

Reference: Long-term testosterone therapy does not increase risk of prostate cancer

Posted in Blog by jbosiljevac

Leave a Comment